- E-mail : info@fortunebiopharm.co.uk
Lenalidomide is one of the novel drug agents used to treat multiple myeloma. It is a more potent molecular analog of thalidomide, which inhibits tumor angiogenesis, tumor secreted cytokines and tumor proliferation through the induction of apoptosis.
Specification:
|
Product name |
Lenalidomide |
|
Synonyms |
3-(7-Amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione |
|
CAS No. |
191732-72-6 |
|
Molecular weight |
259.26 |
|
Molecular Formula |
C13H13N3O3 |
|
Melting Point |
269-271 °C |
|
Boiling point |
614 °C at 760 mmHg |
|
Appearance |
White to light yellow crystalline powder |
|
Test Items |
Specifications |
Results |
|
Appearance |
White to light yellow crystalline powder |
conforms |
|
Water content |
≤ 4.0% |
0.021 |
|
Residuce on ignition |
≤ 0.5% |
0.0032 |
|
Residual Solvents |
Methanol≤ 3000ppm |
1400ppm |
|
Acetonitrile≤ 410ppm |
not detected |
|
|
Carbon tetrachloride≤ 4ppm |
not detected |
|
|
Tetrahydrofuran≤ 720ppm |
250ppm |
|
|
Dimethylformamide ≤ 550ppm |
320ppm |
|
|
Related Substance |
Single Impurity≤1% |
0.004 |
|
Total Impurity≤1.5% |
0.008 |
|
|
Assay |
≥98.0% |
99.6% |
Packaging details:
|
Packaging details: |
25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum. |
|
Storage: |
Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat |
|
Shelf Life: |
5 years if sealed and store away from direct sun light. |
